COMMUNIQUÉS West-GlobeNewswire

Cytokinetics to Participate in March Investor Conferences

03/03/2025 - 22:00

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences in March: [...]

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

03/03/2025 - 22:01

Total Revenue of $71.3 million for FY2024, growing 45% over FY2023; Gross margins of 78% for FY2024, up 5% points over FY2023 ; FY2025 Total Revenue Guidance of $92-95 million; Conference Call and Webcast Today at 4:30 [...]

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

03/03/2025 - 22:01

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS is the first-ever [...]

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

03/03/2025 - 22:05

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage [...]

89bio to Participate in the Leerink Partners Global Healthcare Conference

03/03/2025 - 22:05

SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]

Synergy CHC to Attend 37th Annual ROTH Conference

03/03/2025 - 22:05

WESTBROOK, Maine, March 03, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it will attend the 37 [...]

The Ensign Group Grows in Washington; Adds Its First Operations in Alaska and Oregon

03/03/2025 - 22:05

SAN JUAN CAPISTRANO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]

Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

03/03/2025 - 22:05

Strong patient and physician demand for pivotal REMAIN-1 study highlights urgent need for post-GLP-1 withdrawal weight maintenance solutions; midpoint data analysis anticipated in Q2 2025 and full study enrollment [...]

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

03/03/2025 - 22:05

MOUNTAIN VIEW, Calif. , March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management [...]

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

03/03/2025 - 22:05

FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA (1) of $164.6 Million, a 309% YoY [...]

The Ensign Group Continues Growth in Arizona

03/03/2025 - 22:05

SAN JUAN CAPISTRANO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]

Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference

03/03/2025 - 22:05

BALA CYNWYD, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

03/03/2025 - 22:05

Received FDA approval for Eversense ® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global [...]

Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

03/03/2025 - 22:05

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]

Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

03/03/2025 - 22:05

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 [...]

Amwell makes inducement grant

03/03/2025 - 22:05

BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares [...]

Tenaya Therapeutics Announces Proposed Public Offering

03/03/2025 - 22:10

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

03/03/2025 - 22:23

Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 [...]

Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech & Services Conference

03/03/2025 - 22:30

Nyxoah Participera à la 35 ème Oppenheimer Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgique – 3 mars 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » [...]